Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Laboratoires SMB
Laboratoires SMB
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Pravafenix
Fenofibrate
,
Pravastatin
2011-04-14
2024-2033
Hypercholesterolemia
,
Coronary artery disease
,
Dyslipidemias
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Retinol
healthy volunteers/patients
,
alzheimer disease
,
pancreatic ductal carcinoma
,
neoplasms
,
gastrointestinal neoplasms
,
intestinal neoplasms
,
psoriatic arthritis
,
systemic lupus erythematosus
,
fibrosis
,
thrombosis
,
pancreatic neoplasms
,
heart diseases
,
venous thrombosis
,
colonic neoplasms
,
biliary tract neoplasms
,
esophageal neoplasms
,
hiv infections
,
polyneuropathies
,
rectal neoplasms
,
colorectal neoplasms
,
adenocarcinoma
,
chronic kidney failure
,
kidney diseases
,
microsatellite instability
,
stomach neoplasms
,
atrial fibrillation
,
venous thromboembolism
,
thromboembolism
,
acute coronary syndrome
,
syndrome
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use